Mesenchymal Stromal Cells Prevent Renal Fibrosis in a Rat Model of Unilateral Ureteral Obstruction by Suppressing the Renin-Angiotensin System Via HuR

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2016 Feb 12

PMID 26866372

Citations 18

Authors

Marilena Gregorini

Valeria Corradetti

Chiara Rocca

Eleonora Francesca Pattonieri

Teresa Valsania

Samantha Milanesi

Nicoletta Serpieri

Giulia Bedino

Pasquale Esposito

Carmelo Libetta

Maria Antonietta Avanzini

Melissa Mantelli

Daniela Ingo

Sabrina Peressini

Riccardo Albertini

Antonio Dal Canton

Teresa Rampino

Affiliations

Soon will be listed here.

Abstract

We studied Mesenchymal Stromal Cells (MSC) effects in experimental Unilateral Ureteral Obstruction (UUO), a fibrogenic renal disease. Rats were divided in 5 groups: sham, UUO, MSC treated-UUO, ACEi treated-UUO, MSC+ACEi treated- UUO. Data were collected at 1, 7, 21 days. UUO induced monocyte renal infiltration, tubular cell apoptosis, tubular atrophy, interstitial fibrosis and overexpression of TGFβ, Renin mRNA (RENmRNA), increase of Renin, Angiotensin II (AII) and aldosterone serum levels. Both lisinopril (ACEi) and MSC treatment prevented monocyte infiltration, reduced tubular cell apoptosis, renal fibrosis and TGFβ expression. Combined therapy provided a further suppression of monocyte infiltration and tubular injury. Lisinopril alone caused a rebound activation of Renin-Angiotensin System (RAS), while MSC suppressed RENmRNA and Renin synthesis and induced a decrease of AII and aldosterone serum levels. Furthermore, in in-vitro and in-vivo experiments, MSC inhibit Human antigen R (HuR) trascription, an enhancer of RENmRNA stability by IL10 release. In conclusion, we demonstrate that in UUO MSC prevent fibrosis, by decreasing HuR-dependent RENmRNA stability. Our findings give a clue to understand the molecular mechanism through which MSC may prevent fibrosis in a wide and heterogeneous number of diseases that share RAS activation as common upstream pathogenic mechanism.

Citing Articles

Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment.

Fang Y, Lao P, Tang L, Chen J, Chen Y, Sun L Cell Transplant. 2023; 32:9636897231184611.

PMID: 37395459 PMC: 10328058. DOI: 10.1177/09636897231184611.

CD73-Adenosinergic Axis Mediates the Protective Effect of Extracellular Vesicles Derived from Mesenchymal Stromal Cells on Ischemic Renal Damage in a Rat Model of Donation after Circulatory Death.

Grignano M, Bruno S, Viglio S, Avanzini M, Tapparo M, Ramus M Int J Mol Sci. 2022; 23(18).

PMID: 36142593 PMC: 9501320. DOI: 10.3390/ijms231810681.

Mesenchymal Stem Cell-Derived Exosomes: Toward Cell-Free Therapeutic Strategies in Chronic Kidney Disease.

Cao Q, Huang C, Chen X, Pollock C Front Med (Lausanne). 2022; 9:816656.

PMID: 35386912 PMC: 8977463. DOI: 10.3389/fmed.2022.816656.

Extracellular Vesicles Derived from Mesenchymal Stromal Cells Delivered during Hypothermic Oxygenated Machine Perfusion Repair Ischemic/Reperfusion Damage of Kidneys from Extended Criteria Donors.

Rampino T, Gregorini M, Germinario G, Pattonieri E, Erasmi F, Grignano M Biology (Basel). 2022; 11(3).

PMID: 35336724 PMC: 8945029. DOI: 10.3390/biology11030350.

Kidney Transplants From Donors on Extracorporeal Membrane Oxygenation Prior to Death Are Associated With Better Long-Term Renal Function Compared to Donors After Circulatory Death.

Gregorini M, Ticozzelli E, Abelli M, Grignano M, Pattonieri E, Giacomoni A Transpl Int. 2022; 35:10179.

PMID: 35210934 PMC: 8862176. DOI: 10.3389/ti.2021.10179.

References

Esteban V, Lorenzo O, Ruperez M, Suzuki Y, Mezzano S, Blanco J . Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J Am Soc Nephrol. 2004; 15(6):1514-29. DOI: 10.1097/01.asn.0000130564.75008.f5. View

Klahr S, Morrissey J . Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol. 2002; 283(5):F861-75. DOI: 10.1152/ajprenal.00362.2001. View

Dal Canton A, Corradi A, Stanziale R, Maruccio G, MIGONE L . Glomerular hemodynamics before and after release of 24-hour bilateral ureteral obstruction. Kidney Int. 1980; 17(4):491-6. DOI: 10.1038/ki.1980.57. View

Asanuma H, VanderBrink B, Campbell M, Hile K, Zhang H, Meldrum D . Arterially delivered mesenchymal stem cells prevent obstruction-induced renal fibrosis. J Surg Res. 2010; 168(1):e51-9. PMC: 3008314. DOI: 10.1016/j.jss.2010.06.022. View

Huang Y, Wongamorntham S, Kasting J, McQuillan D, Owens R, Yu L . Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int. 2005; 69(1):105-13. DOI: 10.1038/sj.ki.5000011. View

Ricardo S, Goor H, Eddy A . Macrophage diversity in renal injury and repair. J Clin Invest. 2008; 118(11):3522-30. PMC: 2575702. DOI: 10.1172/JCI36150. View

Duffield J . Macrophages and immunologic inflammation of the kidney. Semin Nephrol. 2010; 30(3):234-54. PMC: 2922007. DOI: 10.1016/j.semnephrol.2010.03.003. View

Chaabane W, Praddaude F, Buleon M, Jaafar A, Vallet M, Rischmann P . Renal functional decline and glomerulotubular injury are arrested but not restored by release of unilateral ureteral obstruction (UUO). Am J Physiol Renal Physiol. 2012; 304(4):F432-9. DOI: 10.1152/ajprenal.00425.2012. View

Aggarwal S, Pittenger M . Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2004; 105(4):1815-22. DOI: 10.1182/blood-2004-04-1559. View

10.

Vernon M, Mylonas K, Hughes J . Macrophages and renal fibrosis. Semin Nephrol. 2010; 30(3):302-17. DOI: 10.1016/j.semnephrol.2010.03.004. View

11.

Rampino T, Gregorini M, Bosio F, Bedino G, Corradetti V, Rocca C . [Mesenchymal stromal cells injection reduces acute rejection damage in a rat experimental model of kidney transplantation]. G Ital Nefrol. 2011; 28(2):132-4. View

12.

Morris B, Adams D, Beveridge D, van der Weyden L, Mangs H, Leedman P . cAMP controls human renin mRNA stability via specific RNA-binding proteins. Acta Physiol Scand. 2004; 181(4):369-73. DOI: 10.1111/j.1365-201X.2004.01307.x. View

13.

Ciccocioppo R, Bernardo M, Sgarella A, Maccario R, Avanzini M, Ubezio C . Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. Gut. 2011; 60(6):788-98. DOI: 10.1136/gut.2010.214841. View

14.

Krishnamurthy P, Lambers E, Verma S, Thorne T, Qin G, Losordo D . Myocardial knockdown of mRNA-stabilizing protein HuR attenuates post-MI inflammatory response and left ventricular dysfunction in IL-10-null mice. FASEB J. 2010; 24(7):2484-94. PMC: 2887267. DOI: 10.1096/fj.09-149815. View

15.

Gregorini M, Bosio F, Rocca C, Corradetti V, Valsania T, Pattonieri E . Mesenchymal stromal cells reset the scatter factor system and cytokine network in experimental kidney transplantation. BMC Immunol. 2014; 15:44. PMC: 4193986. DOI: 10.1186/s12865-014-0044-1. View

16.

Cantaluppi V, Biancone L, Quercia A, Deregibus M, Segoloni G, Camussi G . Rationale of mesenchymal stem cell therapy in kidney injury. Am J Kidney Dis. 2012; 61(2):300-9. DOI: 10.1053/j.ajkd.2012.05.027. View

17.

Chevalier R, Forbes M, Thornhill B . Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 2009; 75(11):1145-1152. DOI: 10.1038/ki.2009.86. View

18.

Ciccocioppo R, Camarca A, Cangemi G, Radano G, Vitale S, Betti E . Tolerogenic effect of mesenchymal stromal cells on gliadin-specific T lymphocytes in celiac disease. Cytotherapy. 2014; 16(8):1080-91. DOI: 10.1016/j.jcyt.2014.03.002. View

19.

Morrissey J, Ishidoya S, McCracken R, KLAHR S . The effect of ACE inhibitors on the expression of matrix genes and the role of p53 and p21 (WAF1) in experimental renal fibrosis. Kidney Int Suppl. 1996; 54:S83-7. View

20.

Rampino T, Gregorini M, Bedino G, Piotti G, Gabanti E, Ibatici A . Mesenchymal stromal cells improve renal injury in anti-Thy 1 nephritis by modulating inflammatory cytokines and scatter factors. Clin Sci (Lond). 2010; 120(1):25-36. DOI: 10.1042/CS20100147. View